Sign In
Buy INCY
$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Incyte Corporation (INCY) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
04:13pm, Thursday, 04'th Sep 2025
Incyte Corporation (NASDAQ:INCY ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:45 AM EDT Company Participants William Meury - CEO, President & Director Pablo Cagnoni - Presid
Incyte Corporation (INCY) Presents At Cantor Global Healthcare Conference 2025 Transcript
11:38am, Wednesday, 03'rd Sep 2025
Incyte Corporation (NASDAQ:INCY ) Cantor Global Healthcare Conference 2025 September 3, 2025 8:00 AM EDT Company Participants William Meury - CEO, President & Director Pablo Cagnoni - President and He
Incyte Launches HS TRUTHS to Spotlight the True Lived Experience of Hidradenitis Suppurativa
09:15am, Wednesday, 03'rd Sep 2025
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #HSTRUTHS--Incyte Launches HS TRUTHS to Spotlight the True Lived Experience of Hidradenitis Suppurativa.
Incyte: Wall Street Underestimates Strength Of Ruxolitinib Portfolio
09:30am, Saturday, 30'th Aug 2025
Incyte's share price continues to soar despite Trump's repeated threats to cut drug prices. One of the key reasons behind the continued upward momentum was Incyte's strong financial results for Q2 202
Can Incyte Deliver on 447% EPS Forecasts and Pipeline Hype?
07:14am, Friday, 29'th Aug 2025
During a year when healthcare stocks, especially biotechnology, have lagged so deeply behind the overall market, it's particularly noteworthy that Incyte Corporation NASDAQ: INCY has managed to stand
Incyte (INCY) Up 9.4% Since Last Earnings Report: Can It Continue?
12:31pm, Thursday, 28'th Aug 2025
Incyte (INCY) reported earnings 30 days ago. What's next for the stock?
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Wednesday, 27'th Aug 2025
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
Incyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources Officer
08:00am, Monday, 25'th Aug 2025
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources Officer.
INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?
11:21am, Wednesday, 20'th Aug 2025
Incyte hits a fresh 52-week high on strong Jakafi and Opzelura sales, pipeline wins and upbeat investor sentiment.
Incyte to Present at Upcoming Investor Conferences
08:00am, Tuesday, 19'th Aug 2025
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte to Present at Upcoming Investor Conferences.
Cancer Stock Soars While This China Tech Stock Heads To New Highs
02:50pm, Friday, 15'th Aug 2025
Cancer stock Incyte soared on earnings and touched a new high on Friday. Also at new highs, Lidar maker Hesai group shows ideal relative strength.
CHICAGO and FORT WORTH, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on d
Incyte Announces Departure of Chief Financial Officer Christiana Stamoulis
04:05pm, Tuesday, 05'th Aug 2025
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Announces Departure of Chief Financial Officer Christiana Stamoulis.
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
08:31am, Friday, 01'st Aug 2025
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
President Trump demands drugmakers slash prices within 60 days
06:54am, Friday, 01'st Aug 2025
CNBC's Joe Kernen reports on the latest news.
